{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:57:31Z","timestamp":1792015051752,"version":"4.4.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"Importance<\/jats:title>Empiric extended-spectrum antibiotics are routinely prescribed for patients hospitalized with skin and soft tissue infections (SSTIs) despite low likelihoods of infection with multidrug-resistant organisms (MDROs).<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate whether computerized provider order entry (CPOE) prompts presenting patient-specific and pathogen-specific MDRO infection risk estimates could reduce empiric extended-spectrum antibiotics for noncritically ill patients admitted with SSTI.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cluster randomized clinical trial included 92 hospitals and assessed the effect of an antibiotic stewardship bundle that included CPOE prompts vs routine stewardship on antibiotic selection during the first 3 hospital days (empiric period) in noncritically ill adults hospitalized with SSTI. The trial population included adults 18 years and older treated with empiric antibiotics for SSTI in non\u2013intensive care unit (ICU) settings. Data were collected from January 2019 to December 2023.<\/jats:p><\/jats:sec>Interventions<\/jats:title>CPOE prompts recommending standard-spectrum antibiotics in patients prescribed extended-spectrum antibiotics during the empiric period when absolute risk of MDRO SSTI was estimated to be less than 10%, coupled with feedback and education.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was empiric extended-spectrum antibiotic days of therapy (summed number of different extended-spectrum antibiotics targeting Pseudomonas<\/jats:italic> and\/or MDR gram-negative bacteria received per patient each calendar day). The secondary outcome was antipseudomonal days of therapy. Safety outcomes included days to ICU transfer and hospital length of stay. Outcomes compared differences between baseline and intervention periods across strategies.<\/jats:p><\/jats:sec>Results<\/jats:title>Among 118\u202f562 patients admitted with SSTI at 92 hospitals, 67\u202f033 (56.7%) were male and the mean (SD) age was 58.0 (17.5) years. A total of 57\u202f837 patients were included in the baseline period and 60\u202f725 in the intervention period. Receipt of any empiric extended-spectrum antibiotic during the baseline and intervention periods was 57.0% (16\u202f855 of 29\u202f595) and 56.0% (17\u202f534 of 31\u202f337), respectively, for the routine stewardship group compared with 55.4% (15\u202f650 of 28\u202f242) and 43.0% (12\u202f647 of 29\u202f388), respectively, for the CPOE group. Empiric extended-spectrum days of therapy per 1000 empiric days targeting Pseudomonas<\/jats:italic> and\/or MDR gram-negative pathogens was 511.5 during the baseline period and 488.7 during the intervention period in the routine stewardship group and was 496.2 and 359.1, respectively, in the CPOE bundle group (rate ratio, 0.72; 95% CI, 0.67-0.79; P<\/jats:italic>\u2009&amp;lt;\u2009.001). There was no evidence of inferiority in the CPOE bundle group for mean (SD) hospital length of stay (routine stewardship, 6.5 [3.8] days; CPOE bundle, 6.4 [3.8] days) and days to ICU transfer (routine stewardship, 6.3 [3.2] days; CPOE bundle, 6.3 [3.1] days).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this randomized clinical trial, CPOE prompts recommending standard-spectrum empiric antibiotics for low-risk patients hospitalized with SSTI coupled with education and feedback significantly reduced use of extended-spectrum antibiotics without increasing admissions to ICUs or hospital length of stay.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT05423756<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamainternmed.2025.0887","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T15:00:26Z","timestamp":1744297226000},"page":"680","source":"Crossref","is-referenced-by-count":19,"title":["Improving Empiric Antibiotic Selection for Patients Hospitalized With Skin and Soft Tissue Infection"],"prefix":"10.1001","volume":"185","author":[{"given":"Shruti K.","family":"Gohil","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Septimus","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kleinman","sequence":"additional","affiliation":[{"name":"Biostatistics and Epidemiology, University of Massachusetts, Amherst"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Varma","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Sands","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts"},{"name":"HCA Healthcare, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taliser R.","family":"Avery","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarah","family":"Mauricio","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selsebil","family":"Sljivo","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Rahm","sequence":"additional","affiliation":[{"name":"HCA Healthcare, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaleb","family":"Roemer","sequence":"additional","affiliation":[{"name":"HCA Healthcare, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Cooper","sequence":"additional","affiliation":[{"name":"HCA Healthcare, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"McLean","sequence":"additional","affiliation":[{"name":"HCA Healthcare, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoise G.","family":"Nickolay","sequence":"additional","affiliation":[{"name":"US Tech Solutions, Jersey City, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell E.","family":"Poland","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts"},{"name":"HCA Healthcare, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Rush University Medical Center, Cook County Health, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir M.","family":"Fakhry","sequence":"additional","affiliation":[{"name":"Center for Trauma and Acute Care Surgery Research, Clinical Services Group, HCA Healthcare, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Guy","sequence":"additional","affiliation":[{"name":"HCA Healthcare, Nashville, Tennessee"},{"name":"Thomas F. Frist, Jr. College of Medicine, Belmont University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Moody","sequence":"additional","affiliation":[{"name":"HCA Healthcare, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela H.","family":"Coady","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim N.","family":"Smith","sequence":"additional","affiliation":[{"name":"HCA Healthcare, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Meador","sequence":"additional","affiliation":[{"name":"HCA Healthcare, Nashville, Tennessee"},{"name":"US Tech Solutions, Jersey City, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Froman","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katyuska","family":"Eibensteiner","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Hayden","sequence":"additional","affiliation":[{"name":"Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Kubiak","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenette","family":"Burks","sequence":"additional","affiliation":[{"name":"HCA Healthcare, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Hayley","family":"Burgess","sequence":"additional","affiliation":[{"name":"Inovalon, Bowie, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Calderwood","sequence":"additional","affiliation":[{"name":"Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Perlin","sequence":"additional","affiliation":[{"name":"HCA Healthcare, Nashville, Tennessee"},{"name":"now with The Joint Commission, Oakbrook Terrace, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Platt","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of California, Irvine School of Medicine, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"ioi250019r1","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"9","key":"ioi250019r2","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3201\/eid1509.081228","article-title":"Trends in US hospital admissions for skin and soft tissue infections.","volume":"15","author":"Edelsberg","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"ioi250019r3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12879-015-1071-0","article-title":"Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010.","volume":"15","author":"Miller","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"6","key":"ioi250019r4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae267","article-title":"The incidence of skin and soft tissue infections in the United States and associated healthcare utilization between 2010 and 2020.","volume":"11","author":"Vella","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"ioi250019r5","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx188","article-title":"Guidelines vs actual management of skin and soft tissue infections in the emergency department.","volume":"5","author":"Kamath","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"ioi250019r6","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1001\/archinternmed.2011.29","article-title":"Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess.","volume":"171","author":"Jenkins","year":"2011","journal-title":"Arch Intern Med"},{"key":"ioi250019r7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jgar.2020.02.002","article-title":"Antimicrobial stewardship in patients with acute bacterial skin and skin-structure infections: an international Delphi consensus.","volume":"22","author":"Soriano","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"ioi250019r8","article-title":"IWGDF\/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF\/IDSA 2023).","author":"Senneville","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ioi250019r9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/QCO.0000000000000431","article-title":"Treatment of severe skin and soft tissue infections: a review.","volume":"31","author":"Burnham","year":"2018","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"ioi250019r10","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jemermed.2014.12.001","article-title":"Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital.","volume":"48","author":"Pollack","year":"2015","journal-title":"J Emerg Med"},{"key":"ioi250019r11","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1093\/cid\/ciz002","article-title":"Current epidemiology, etiology, and burden of acute skin infections in the United States.","volume":"68","author":"Kaye","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"7","key":"ioi250019r12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac297","article-title":"Prevalence and predictors of Pseudomonas aeruginosa among hospitalized patients with diabetic foot infections.","volume":"9","author":"Veve","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"ioi250019r13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/QCO.0000000000000642","article-title":"Risk stratification for multidrug-resistant bacteria in patients with skin and soft tissue infection.","volume":"33","author":"Barbier","year":"2020","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"ioi250019r14","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2022.316","article-title":"Characterizing barriers to antibiotic stewardship for skin and soft-tissue infections in the emergency department using a systems engineering framework.","volume":"2","author":"Pulia","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"9","key":"ioi250019r15","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of adverse events with antibiotic use in hospitalized patients.","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"1","key":"ioi250019r17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.","volume":"53","author":"Stevens","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"23","key":"ioi250019r18","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1001\/jama.2024.6248","article-title":"Stewardship prompts to improve antibiotic selection for pneumonia: the INSPIRE randomized clinical trial.","volume":"331","author":"Gohil","year":"2024","journal-title":"JAMA"},{"issue":"23","key":"ioi250019r19","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1001\/jama.2024.6259","article-title":"Stewardship prompts to improve antibiotic selection for urinary tract infection: the INSPIRE randomized clinical trial.","volume":"331","author":"Gohil","year":"2024","journal-title":"JAMA"},{"key":"ioi250019r20","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2025.1108","article-title":"Improving empiric antibiotic selection for patients hospitalized with abdominal infection: the INSPIRE 4 randomized clinical trial.","author":"Gohil","journal-title":"JAMA Surg"},{"key":"ioi250019r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2021.100746","article-title":"Matching in cluster randomized trials using the Goldilocks approach.","volume":"22","author":"Sturdevant","year":"2021","journal-title":"Contemp Clin Trials Commun"},{"issue":"12","key":"ioi250019r24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.40798","article-title":"Variation by race in antibiotics prescribed for hospitalized patients with skin and soft tissue infections.","volume":"4","author":"Wurcel","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ioi250019r25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/1471-2334-13-252","article-title":"Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study.","volume":"13","author":"Ray","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"6","key":"ioi250019r26","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.jaad.2022.08.038","article-title":"Racial and ethnic differences in hospital admissions for cellulitis in the United States: a cross-sectional analysis.","volume":"87","author":"Zheng","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"ioi250019r27","first-page":"19","article-title":"Racial and ethnic differences among adult patients hospitalized for skin and soft tissue infection: a cross-sectional analysis of 2012-2017 New York State data.","volume":"16","author":"Sedghi","year":"2023","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"ioi250019r28","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s40615-023-01584-8","article-title":"Skin Pigmentation Impacts the Clinical Diagnosis of Wound Infection: Imaging of Bacterial Burden to Overcome Diagnostic Limitations.","volume":"11","author":"Johnson","year":"2024","journal-title":"J Racial Ethn Health Disparities"},{"issue":"5","key":"ioi250019r29","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s00125-010-1672-5","article-title":"Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost.","volume":"53","author":"Lipsky","year":"2010","journal-title":"Diabetologia"},{"issue":"2","key":"ioi250019r30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1128\/JCM.05817-11","article-title":"Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients.","volume":"50","author":"Zervos","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"2","key":"ioi250019r31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/jamainternmed.2024.6436","article-title":"When can a MRSA nares swab guide antibiotic stewardship? what the nose knows.","volume":"185","author":"Saito","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"1","key":"ioi250019r32","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2023.444","article-title":"Use of nares swab to de-escalate vancomycin for patients with suspected methicillin-resistant Staphylococcus aureus.","volume":"3","author":"Gentges","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"ioi250019r21","volume-title":"On the Generalised Distance in Statistics","author":"Mahalanobis","year":"1936"},{"key":"ioi250019r16","unstructured":"Centers for Disease Control and Prevention. 2019 Antibiotic Resistance Threats Report. Accessed December 10, 2024. https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/index.html"},{"key":"ioi250019r23","unstructured":"Agency for Healthcare Research and Quality. Elixhauser Comorbidity Software Refined for ICD-10-CM. Accessed September 12, 2024. https:\/\/hcup-us.ahrq.gov\/toolssoftware\/comorbidityicd10\/comorbidity_icd10.jsp"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2832776\/jamainternal_gohil_2025_oi_250019_1748025360.91629.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T15:01:25Z","timestamp":1748876485000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2832776"}},"subtitle":["The INSPIRE 3 Skin and Soft Tissue Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2025.0887","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}